LivaNova PLC (NASDAQ:LIVN) Receives $64.40 Average PT from Analysts

Shares of LivaNova PLC (NASDAQ:LIVN) have earned a consensus recommendation of “Hold” from the five brokerages that are currently covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $64.40.

A number of analysts recently issued reports on LIVN shares. Barclays raised their target price on shares of LivaNova from $57.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, February 26th. Robert W. Baird lifted their price objective on LivaNova from $56.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, February 22nd. Mizuho reiterated a “buy” rating and set a $75.00 target price on shares of LivaNova in a research report on Wednesday, March 27th. StockNews.com raised LivaNova from a “hold” rating to a “buy” rating in a research note on Thursday. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $72.00 price objective on shares of LivaNova in a research note on Wednesday, March 20th.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Headlands Technologies LLC acquired a new position in LivaNova during the third quarter valued at approximately $72,000. Picton Mahoney Asset Management purchased a new position in shares of LivaNova in the 3rd quarter valued at $91,000. Vanguard Personalized Indexing Management LLC acquired a new position in shares of LivaNova during the 3rd quarter valued at $217,000. AlphaMark Advisors LLC purchased a new stake in LivaNova during the 3rd quarter worth $244,000. Finally, Jump Financial LLC acquired a new stake in LivaNova in the 3rd quarter valued at $273,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

LivaNova Stock Performance

LivaNova stock opened at $55.94 on Monday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.51 and a current ratio of 2.95. The company has a market capitalization of $3.02 billion, a price-to-earnings ratio of 174.82 and a beta of 0.89. LivaNova has a fifty-two week low of $42.75 and a fifty-two week high of $59.86. The stock has a fifty day moving average of $53.92 and a two-hundred day moving average of $50.59.

LivaNova (NASDAQ:LIVN) last announced its earnings results on Wednesday, February 21st. The company reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.10. The firm had revenue of $310.10 million during the quarter, compared to the consensus estimate of $287.65 million. LivaNova had a net margin of 1.53% and a return on equity of 12.23%. The firm’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.81 EPS. On average, analysts anticipate that LivaNova will post 3.01 EPS for the current fiscal year.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.